A Tale from the Dusty Corner: Galera Therapeutics Inc (GRTX) Stock
Piper Sandler lowered the price target for the Galera Therapeutics Inc (NASDAQ:GRTX) stock from “an Overweight” to “a Neutral”. The rating was released on August 10, 2023, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Underperform, with a price target set at $2. The stock was resumed […]
Is Galera Therapeutics Inc (GRTX) Stock A Better Investment Than Its Rivals?
Piper Sandler lowered the price target for the Galera Therapeutics Inc (NASDAQ:GRTX) stock from “an Overweight” to “a Neutral”. The rating was released on August 10, 2023, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Underperform, with a price target set at $2. The stock was resumed […]
Galera Therapeutics Inc (GRTX) Stock to return to profitability in the near future
Piper Sandler lowered the price target for the Galera Therapeutics Inc (NASDAQ:GRTX) stock from “an Overweight” to “a Neutral”. The rating was released on August 10, 2023, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Underperform, with a price target set at $2. The stock was resumed […]
What are the chances of the Galera Therapeutics Inc (GRTX) Stock tortoise growing into a hare?
Piper Sandler lowered the price target for the Galera Therapeutics Inc (NASDAQ:GRTX) stock from “an Overweight” to “a Neutral”. The rating was released on August 10, 2023, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Underperform, with a price target set at $2. The stock was resumed […]
Galera Therapeutics Inc (GRTX) Stock is looking to regain its victory
Piper Sandler lowered the price target for the Galera Therapeutics Inc (NASDAQ:GRTX) stock from “an Overweight” to “a Neutral”. The rating was released on August 10, 2023, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Underperform, with a price target set at $2. The stock was resumed […]
Risks and Returns of Galera Therapeutics Inc (GRTX) Stock
Piper Sandler lowered the price target for the Galera Therapeutics Inc (NASDAQ:GRTX) stock from “an Overweight” to “a Neutral”. The rating was released on August 10, 2023, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Underperform, with a price target set at $2. The stock was resumed […]
